Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 4/20 | 1.00 |
| ▸ | XDH | P47989 | 4/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 4/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 3/20 | 1.00 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | CA7 | P43166 | 2/20 | 1.00 |
| ▸ | NQO2 | P16083 | 1/20 | 0.85 |
| ▸ | MAPT | P10636 | 5/20 | 0.84 |
| ▸ | POLB | P06746 | 4/20 | 0.84 |
| ▸ | GAA | P10253 | 4/20 | 0.84 |
| ▸ | KDM1A | O60341 | 2/20 | 0.84 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercitrin SCHEMBL29454400 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL117644 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL5456136 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL4227921 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL17628907 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL811472 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL6849807 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL15337986 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL3206092 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL29381705 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3141253-B1 | COMPATIBLE COMPOSITION CONTAINING CHINESE MEDICINE CICHORIUM GLANDULOSUM BOISS ET HOUT AS LIPID-LOWERING ACTIVE INGREDIENT | NANJING RUIYING RUNZE BIOPHARMACEUTICAL TECH CO INC (CN) | 2019-10-02 | — | — | EP | claimed |
| EP-1300084-B1 | Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves | BOEHRINGER INGELHEIM INT (DE) | 2006-04-19 | — | — | EP | claimed |
| EP-1225810-B1 | METHOD FOR TREATMENT OF CHRONIC VENOUS INSUFFICIENCIES USING AN EXTRACT OF RED VINE LEAVES | BOEHRINGER INGELHEIM INT (DE) | 2003-03-26 | — | — | EP | claimed |
| US-10391113-B2 | Compatible composition containing chinese medicine cichorium glandulosum boiss et hout as lipid-lowering active ingredient | NANJING RUIYING RUNZE BIOPHARMAEUTICAL TECHNOLOGY CO., INC. (CN) | 2019-08-27 | — | — | US | disclosed |
| US-20170100421-A1 | Compatible Composition Containing Chinese Medicine Cichorium Glandulosum Boiss Et Hout As Lipid-Lowering Active Ingredient | NANJING RUIYING RUNZE BIOPHARMACEUTICAL TECHNOLOGY CO., INC. (CN) | 2017-04-13 | — | — | US | disclosed |
| EP-3141253-A1 | COMPATIBLE COMPOSITION CONTAINING CHINESE MEDICINE CICHORIUM GLANDULOSUM BOISS ET HOUT AS LIPID-LOWERING ACTIVE INGREDIENT | Nanjing Ruiying Runze Biopharmaceutical Technology Co., Inc. (CN) | 2017-03-15 | — | — | EP | disclosed |
| EP-2575844-B1 | Method for producing an enriched extract from vine plants | FINZELBERG GMBH & CO KG (DE) | 2016-11-23 | — | — | EP | disclosed |
| WO-2015169122-A1 | COMPATIBLE COMPOSITION CONTAINING CHINESE MEDICINE CICHORIUM GLANDULOSUM BOISS ET HOUT AS LIPID-LOWERING ACTIVE INGREDIENT | 南京睿鹰润泽生物医药科技有限公司 | 2015-11-12 | — | — | WO | disclosed |
| EP-2575844-A1 | PROCESS FOR THE PREPARATION OF AN ENRICHED EXTRACT FROM GRAPE VINE PLANT LEAVES | Finzelberg GmbH & Co. KG (DE) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011147989-A1 | PROCESS FOR THE PREPARATION OF AN ENRICHED EXTRACT FROM GRAPE VINE PLANT LEAVES | FINZELBERG GMBH & CO. KG (DE) | 2011-12-01 | — | — | WO | disclosed |
| EP-2161025-A1 | Method for producing an extract from vegetable material of the type Rumex acetosa L. | Engelhard Arzneimittel GmbH & Co. KG (DE) | 2010-03-10 | — | — | EP | disclosed |
| WO-2006090206-A1 | IMPROVED EXTRACTS OF PSIDIUM GUAJAVA L., METHODS FOR ITS OBTAINING AND USE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | LOZOYA LEGORRETA XAVIER (MX) | 2006-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170100421-A1 | Compatible Composition Containing Chinese Medicine Cichorium Glandulosum Boiss Et Hout As Lipid-Lowering Active Ingredient | CPT1A, HMGCR, SLC2A8 | P4HB 3119/4885KDM4E 3147/4885L3MBTL1 1476/4885 |
| US-10391113-B2 | Compatible composition containing chinese medicine cichorium glandulosum boiss et hout as lipid-lowering active ingredient | CPT1A, HMGCR, SLC2A8 | P4HB 3119/4885KDM4E 3147/4885L3MBTL1 1476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.